In this webinar, partners Michael Stott and Posy Drywood discuss how and why objections over intermediate generalisation arise, the arguments that are most likely to be effective when faced with them, and drafting tips and tricks that can help avoid them altogether.
Watch nowIn this webinar, Mathys & Squire partners Stephen Garner and Anna Gregson explore the impact of clinical trials on the assessment of sufficiency and inventive step, while exploring recent EPO case law.
Watch nowThe European Patent Office’s strict approach to the assessment of written basis can be a potential minefield for applicants looking to amend around prior art. Partners Martin MacLean and David Hobson provide their tips and tricks to build into your drafting practice to safeguard against common pitfalls.
Watch nowIn this webinar, attorneys Jeremy Smith and Alexander Robinson take a look at the European Patent Office’s approach to the developing field AI in life sciences, including an overview of the fundamentals of AI together with case studies highlighting important issues for life sciences AI inventions in particular.
Watch nowA new 2021 edition of the EPO Guidelines for Examination will come into effect in March 2021, with significant revisions regarding the requirement to amend the description for conformity with the claims expected. In this webinar, partners Hazel Ford and Andrew White discuss the potential implications of these changes.
Watch nowIn this webinar, partners Sean Leach, Andrew White and Juliet Redhouse discuss some of the relatively under-used and cost-effective options available to practitioners in challenging third party patents and patent applications both pre- and post-grant.
Watch nowIn this webinar, Mathys & Squire partners Andreas Wietzke and Andrew White are joined by IP specialist barrister Edward Cronan from Hogarth Chambers to discuss recent Standard Essential Patent (SEP) litigation cases in Europe.
Watch nowOur presenters, Stephen Garner and Anna Gregson, discuss how EPO case law has developed since revocation of the dasatinib patent in 2017, and explore how innovators should adjust their filing and drafting strategy in light of the EPO’s post-dasatinib approach to plausibility.
Watch nowThis webinar explores the different types of IP, including how to protect the value in your brands, confidentiality, NDAs and ownership, as well as how patents and registered designs are used in practice. Our presenters, Sam Giles and Harry Rowe, using a range of commercial case studies, illustrate the importance of IP to a business.
Watch now